Influence of invasive aspergillosis during acute leukaemia treatment on survival after allogeneic stem cell transplantation: a prospective study of the EBMT Infectious Diseases Working Party

被引：3

作者：

Penack, Olaf ^{[1
,45
,46
]}

Tridello, Gloria ^{[2
]}

Salmenniemi, Urpu ^{[3
]}

Martino, Rodrigo ^{[4
]}

Khanna, Nina ^{[5
]}

Perruccio, Katia ^{[6
]}

Fagioli, Franca ^{[7
]}

Richert-Przygonska, Monika ^{[8
]}

Labussiere-Wallet, Helene ^{[9
]}

Maertens, Johan ^{[10
]}

Jubert, Charlotte ^{[11
]}

Aljurf, Mahmoud ^{[12
]}

Pichler, Herbert ^{[13
]}

Krivan, Gergely ^{[14
]}

Kunadt, Desiree ^{[15
]}

Popova, Marina ^{[16
]}

Gabriel, Melissa ^{[17
]}

Calore, Elisabetta ^{[18
]}

Blau, Igor Wolfgang ^{[1
]}

Benedetti, Fabio ^{[19
]}

Itala-Remes, Maija ^{[20
]}

de Kort, Elizabeth ^{[21
]}

Russo, Domenico ^{[22
]}

Faraci, Maura ^{[23
]}

Menard, Anne-Lise ^{[24
]}

von dem Borne, Peter ^{[25
]}

Poire, Xavier ^{[26
]}

Yesilipek, Akif ^{[27
]}

Gozdzik, Jolanta ^{[28
]}

Yegin, Zeynep Arzu ^{[29
]}

Yanez, Lucrecia ^{[30
]}

Facchini, Luca ^{[31
]}

Van Gorkom, Gwendolyn ^{[32
]}

Thurner, Lorenz ^{[33
]}

Kocak, Ulker ^{[34
]}

Sampol, Antonia ^{[35
]}

Zuckerman, Tsila ^{[36
]}

Bierings, Marc ^{[37
]}

Mielke, Stephan ^{[38
]}

Ciceri, Fabio ^{[39
]}

Wendel, Lotus ^{[2
]}

Knelange, Nina ^{[2
]}

Mikulska, Malgorzata ^{[40
,41
]}

Averbuch, Dina ^{[42
]}

Styczynski, Jan ^{[8
]}

de la Camara, Rafael ^{[43
]}

Cesaroaq, Simone ^{[44
]}

机构：

[1] Med Klin m S Hamatol Onkol & Tumorimmunol, Berlin, Germany

[2] EBMT Leiden Study Unit, Leiden, Netherlands

[3] HUCH Comprehens Canc Ctr, Helsinki, Finland

[4] Hosp Sant Creu i Sant Pau, Barcelona, Spain

[5] Univ Basel Hosp, Div Infect Dis, Basel, Switzerland

[6] Santa Maria Della Misericordia Hosp, Pediat Oncol Hematol & Stem Cell Transplantat Prog, Perugia, Italy

[7] Osped Infantile Regina Margher, Turin, Italy

[8] Nicolaus Copernicus Univ Torun, Jurasz Univ Hosp, Dept Pediat Hematol & Oncol, Coll Medicum, Bydgoszcz, Poland

[9] Hosp Civils Lyon, Hop Lyon Sud, Pierre Benite, France

[10] Univ Hosp Gasthuisberg, Leuven, Belgium

[11] CHU Bordeaux Grp Hosp Pellegrin Enfants, Bordeaux, France

[12] King Faisal Specialist Hosp & Res Ctr, Riyadh, Saudi Arabia

[13] Med Univ Vienna, St Anna Childrens Hosp, Dept Pediat & Adolescent Med, Vienna, Austria

[14] Cent Hosp Southern Pest, Budapest, Hungary

[15] Tech Univ Dresden, Univ Hosp, Dresden, Germany

[16] Pavlov Univ, RM Gorbacheva Res Inst, St Petersburg, Russia

[17] Childrens Hosp Westmead, Canc Ctr Children, Sydney, Australia

[18] Univ Padua, Azienda Osped, Dept Womens & Childrens Hlth, Pediat Hematol Oncol & Stem Cell Transplant Div, Padua, Italy

[19] Policlin GB Rossi, Verona, Italy

[20] Turku Univ Hosp, Turku, Finland

[21] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands

[22] Brescia Univ, Unit Blood Dis & Bone Marrow Transplantat, Brescia, Italy

[23] IRCCS Ist G Gaslini, Dept Hematol Oncol, HSCT Unit, Genoa, Italy

[24] Ctr Henri Becquerel, Rouen, France

[25] Leiden Univ Hosp, Leiden, Netherlands

[26] Clin Univ St Luc, Brussels, Belgium

[27] Med Pk Antalya Hosp, Antalya, Turkiye

[28] Jagiellonian Univ Med Collage, Univ Childrens Hosp Krakow, Dept Clin Immunol & Transplantat, Krakow, Poland

[29] Gazi Univ, Fac Med, Ankara, Turkiye

[30] Hosp U Marques de Valdecilla IDIVAL, Santander, Spain

[31] AUSL IRCCS Reggio Emilia, Hematol, Reggio Emilia, Italy

[32] Univ Hosp Maastricht, Maastricht, Netherlands

[33] Univ Saarland, Lorenz Thurner, Homburg, Germany

[34] Gazi Univ, Sch Med, Ankara, Turkiye

[35] Hosp Son Espases, Palma De Mallorca, Balearic Island, Spain

[36] Technion, Rambam Med Ctr, Fac Med, Haifa, Israel

[37] Univ Hosp Children WKZ, Princess Maxima Ctr, Utrecht, Netherlands

[38] Karolinska Univ Hosp, Stockholm, Sweden

[39] Univ V Salute San Raffaele, Milan, Italy

[40] Univ Genoa, Div Infect Dis, Genoa, Italy

[41] Osped Policlin San Martino, Genoa, Italy

[42] Hebrew Univ Jerusalem, Fac Med, Hadassah Med Ctr, Pediat Infect Dis, Jerusalem, Israel

[43] Hosp Princesa, Madrid, Spain

[44] Azienda Osped Univ Integrata, Dept Mother & Child, Pediat Hematol Oncol, Verona, Italy

[45] Charite, Dept Hematol Oncol & Tumorimmunol, Campus Virchow Klinikum, Augustenburger Pl 1, D-13353 Berlin, Germany

[46] Charite Univ Med Berlin, Dept Hematol Oncol & Tumorimmunol, Campus Virchow Clin, Augustenburger Pl 1, D-13353 Berlin, Germany

来源：

ECLINICALMEDICINE | 2024年 / 67卷

关键词：

Invasive; Aspergillosis; Stem cell transplantation; Mortality; SECONDARY ANTIFUNGAL PROPHYLAXIS; HEMATOLOGICAL MALIGNANCIES; NEUTROPENIC PATIENTS; FUNGAL-INFECTION; EXPERIENCE; SOCIETY; IMPACT; BLOOD; HSCT;

D O I：

10.1016/j.eclinm.2023.102393

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Background Infections are the main reason for mortality during acute leukaemia treatment and invasive aspergillosis (IA) is a major concern. Allogeneic stem cell transplantation (alloSCT) is a standard therapy and often is the only saving procedure in leukaemia patients. The profound immunodeficiency occurring after alloSCT led to high associated mortality in the past. Therefore, patients with IA were historically considered transplant-ineligible. Recently, there has been improvement of anti-fungal management including novel anti-fungal agents. As a result, more leukaemia patients with IA are undergoing alloSCT. Outcome has not been prospectively assessed. Methods We performed a prospective study in acute leukaemia patients undergoing alloSCT to analyse the impact a prior history of probable or proven IA (pre-SCT IA). The primary endpoint was 1-year non-relapse mortality (NRM). Relapse free survival and overall survival were analysed as secondary endpoints. Findings 1439 patients were included between 2016 and 2021. The incidence of probable or proven pre-SCT IA was (n = 87). The cumulative incidence of 1-year NRM was 17.3% (95% CI 10.2-26.0) and 11.2% (9.6-13.0) for patients and without pre-SCT IA. In multivariate analyses the hazard ratio (HR) for 1-year NRM was 2.1 (1.2-3.6; p = 0.009) patients with pre-SCT IA. One-year relapse-free survival was inferior in patients with pre-SCT IA (59.4% [48.3-68.9] 70.4 [67.9-72.8]; multivariate HR 1.5 [1.1-2.1]; p = 0.02). Consequently, 1-year overall survival was lower in patients with pre-SCT IA: (68.8% [57.8-77.4] vs. 79.0% [76.7-81.1]; multivariate HR 1.7 [1.1-2.5]; p = 0.01). Interpretation Pre-SCT IA remains to be significantly associated with impaired alloSCT outcome. On the other more than two thirds of patients with pre-SCT IA were alive at one year after alloSCT. IA is not anymore an absolute contraindication for alloSCT because the majority of patients with IA who undergo alloSCT benefit from this procedure.

引用

页数：10

共 50 条

[31] Pneumocystis Pneumonia After Allogeneic Hematopoietic Cell Transplantation: A Case-Control Study on Epidemiology and Risk Factors on Behalf of the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation
Robin, Christine
Cordonnier, Catherine
Tridello, Gloria
Knelange, Nina
Xhaard, Alienor
Chantepie, Sylvain
Tanguy-Schmidt, Aline
Schouten, Harry C.
Yeshurun, Moshe
Rocha, Vanderson
Srour, Micha
Kroeger, Nicolaus
Ledoux, Marie-Pierre
Dalgaard, Jakob
Thiebaut, Anne
Giardino, Stefano
Calore, Elisabetta
Zuckerman, Tsila
Groll, Andreas H.
Raida, Ludek
Avcin, Simona
Vicent, Marta Gonzalez
Kaare, Ain
Drozd-Sokolowska, Joanna
Turlure, Pascal
Bretagne, Stephane
Mikulska, Malgorzata
de la Camara, Rafael
Cesaro, Simone
Styczynski, Jan
TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (02): : 235.e1 - 235.e10
[32] Incidence, Risk Factors, and Long-term Outcome of Acute Leukemia Patients With Early Candidemia After Allogeneic Stem Cell Transplantation: A Study by the Acute Leukemia and Infectious Diseases Working Parties of European Society for Blood and Marrow Transplantation
Cesaro, Simone
Tridello, Gloria
Blijlevens, Nicole
Ljungman, Per
Craddock, Charles
Michallet, Mauricette
Martin, Alexander
Snowden, John A.
Mohty, Mohamad
Maertens, Johan
Passweg, Jacob
Petersen, Eefke
Nihtinen, Anne
Isaksson, Cecilia
Milpied, Noel
Rohlich, Pierre-Simon
Deconinck, Eric
Crawley, Charles
Ledoux, Marie-Pierre
Hoek, Jennifer
Nagler, Arnon
Styczynski, Jan
CLINICAL INFECTIOUS DISEASES, 2018, 67 (04) : 564 - 572
[33] Effect of the Thiotepa Dose in the TBF Conditioning Regimen in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Complete Remission: A Report From the EBMT Acute Leukemia Working Party
El-Cheikh, Jean
Labopin, Myriam
Al-Chami, Farouk
Bazarbachi, Ali
Angelucci, Emanuele
Santarone, Stella
Bonifazi, Francesca
Carella, Angelo Michele
Castagna, Luca
Bruno, Benedetto
Iori, Anna Paola
La Nasa, Giorgio
Savani, Bipin
Nagler, Arnon
Mohty, Mohamad
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (05) : 296 - 304
[34] Long-term outcome analysis of reduced-intensity allogeneic stem cell transplantation in patients with mantle cell lymphoma: a retrospective study from the EBMT Lymphoma Working Party
Robinson, Stephen P.
Boumendil, Ariane
Finel, Herve
Peggs, Karl S.
Chevallier, Patrice
Sierra, Jorge
Finke, Juergen
Poire, Xavier
Maillard, Natacha
Milpied, Noel
Yakoub-Agha, Ibrahim
Koh, Mickey
Kroeger, Nicolaus
Nagler, Arnon
Koc, Yener
Dietrich, Sascha
Montoto, Silvia
Dreger, Peter
BONE MARROW TRANSPLANTATION, 2018, 53 (05) : 617 - 624
[35] Allogeneic haematopoietic stem cell transplantation for infant acute lymphoblastic leukaemia with KMT2A (MLL) rearrangements: a retrospective study from the paediatric acute lymphoblastic leukaemia working group of the Japan Society for Haematopoietic Cell Transplantation
Kato, Motohiro
Hasegawa, Daiichiro
Koh, Katsuyoshi
Kato, Keisuke
Takita, Junko
Inagaki, Jiro
Yabe, Hiromasa
Goto, Hiroaki
Adachi, Souichi
Hayakawa, Akira
Takeshita, Yasufumi
Sawada, Akihisa
Atsuta, Yoshiko
Kato, Koji
BRITISH JOURNAL OF HAEMATOLOGY, 2015, 168 (04) : 564 - 570
[36] T-Cell-Depleted Haploidentical Stem Cell Transplantation Results Improve With Time in Adults With Acute Leukemia: A Study From the Acute Leukemia Working Party of the European Society of Blood and Marrow Transplantation (EBMT)
Sestili, Simona
Labopin, Myriam
Ruggeri, Annalisa
Velardi, Andrea
Ciceri, Fabio
Maertens, Johan
Kanz, Lothar
Aversa, Franco
Lewalle, Philippe
Bunjes, Donald
Mohty, Mohamad
Nagler, Arnon
CANCER, 2018, 124 (10) : 2142 - 2150
[37] Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party
Scheid, C.
de Wreede, L.
van Biezen, A.
Koenecke, C.
Gohring, G.
Volin, L.
Maertens, J.
Finke, J.
Passweg, J.
Beelen, D.
Cornelissen, J. J.
Itaelae-Remes, M.
Chevallier, P.
Russell, N.
Petersen, E.
Milpied, N.
Espiga, C. Richard
Peniket, A.
Sierra, J.
Mufti, G.
Crawley, C.
Veelken, J. H.
Ljungman, P.
Cahn, J. Y.
Alessandrino, E. P.
de Witte, T.
Robin, M.
Kroeger, N.
BONE MARROW TRANSPLANTATION, 2017, 52 (11) : 1519 - 1525
[38] Risk of complications during hematopoietic stem cell collection in pediatric sibling donors: a prospective European Group for Blood and Marrow Transplantation Pediatric Diseases Working Party study
Styczynski, Jan
Balduzzi, Adriana
Gil, Lidia
Labopin, Myriam
Hamladji, Rose-Marie
Marktel, Sarah
Yesilipek, M. Akif
Fagioli, Franca
Ehlert, Karoline
Matulova, Martina
Dalle, Jean-Hugues
Wachowiak, Jacek
Miano, Maurizio
Messina, Chiara
Diaz, Miguel Angel
Vermylen, Christiane
Eyrich, Matthias
Badell, Isabel
Dreger, Peter
Gozdzik, Jolanta
Hutt, Daphna
Rascon, Jelena
Dini, Giorgio
Peters, Christina
BLOOD, 2012, 119 (12) : 2935 - 2942
[39] Allogeneic haematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for lymphoma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT
Nabergoj, Mitja
Eikema, Diderik-Jan
Koster, Linda
Platzbecker, Uwe
Sockel, Katja
Finke, Juergen
Kroeger, Nicolaus
Forcade, Edouard
Nagler, Arnon
Eder, Matthias
Tischer, Johanna
Broers, Annoek E. C.
Kuball, Juergen
Wilson, Keith M. O.
Hunault-Berger, Mathilde
Collin, Matthew
Russo, Domenico
Corral, Lucia Lopez
Helbig, Grzegorz
Mussetti, Alberto
Scheid, Christof
Gurnari, Carmelo
Raj, Kavita
Drozd-Sokolowska, Joanna
Yakoub-Agha, Ibrahim
Robin, Marie
Mclornan, Donal P.
BONE MARROW TRANSPLANTATION, 2024, 59 (03) : 395 - 402
[40] Current practices used for the prevention of central venous catheter-associated infection in hematopoietic stem cell transplantation recipients: a survey from the Infectious Diseases Working Party and Nurses' Group of EBMT
Snarski, E.
Mank, A.
Iacobelli, S.
Hoek, J.
Styczynski, J.
Babic, A.
Cesaro, S.
Johansson, E.
TRANSPLANT INFECTIOUS DISEASE, 2015, 17 (04) : 558 - 565

← 1 2 3 4 5 →